Safety

rheuma-online: Ein Update zum Lymphomrisiko unter MTX und anti-TNF Therapie der National Data Bank for Rheumatic Diseases, Wichita, Kansas, USA

Frederick Wolfe, Kaleb Michaud
The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person years of observation
Arthritis & Rheumatism 2007; 56, 5: 1433 – 1439

E.H. Giannini, N.T. Ilowite, D.J. Lovell, C.A. Wallace, C.E. Rabinovich, A.O. Reiff, G. Higgins, Y. Chon, S. Lin
EULAR 2007 [SAT0397] The long.term safety ofetanercept in children with polyarticular or systemic juvenile arthritis
Ann Rheum Dis 2007; 66(Suppl II):550

Roux CH, Brocq O, Breuil V, Albert C, Euller-Ziegler L.
Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy.
Rheumatology (Oxford). 2007 Apr;46(4):695-8.

Stone JH, Holbrook JT, Marriott MA, Tibbs AK, Sejismundo LP, Min YI, Specks U, Merkel PA, Spiera R, Davis JC, St Clair EW, McCune WJ, Ytterberg SR, Allen NB, Hoffman GS
Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial.
Arthritis Rheum. 2006 May;54(5):1608-18. 

Mann DL, McMurray JJ, Packer M, Swedberg K, Borer JS, Colucci WS, Djian J, Drexler H, Feldman A, Kober L, Krum H, Liu P, Nieminen M, Tavazzi L, van Veldhuisen DJ, Waldenstrom A, Warren M, Westheim A, Zannad F, Fleming T.
Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).
Circulation. 2004 Apr 6;109(13):1594-602

Genovese MC, Cohen S, Moreland L, Lium D, Robbins S, Newmark R, Bekker P
Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.
Arthritis Rheum. 2004 May;50(5):1412-9.